Use of danazol in conservative surgery

Buttram Vc, Buttram VC Jr, V C Buttram
The Journal of reproductive medicine · 1990 · vol. 35(1 Suppl) , pp. 82–4; discussion 84 · PMID:2404117 · W2416298389
Review OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

A six-month preoperative danazol regimen reduced pelvic vascularity and inflammation, potentially decreasing postoperative adhesion formation and enabling more laparoscopic surgeries.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Any type of injury, inflammation or noninfectious condition can cause an adhesion. Among noninfectious conditions that cause adhesions, endometriosis is the most common. a six-month preoperative regimen of Danocrine (danazol) resulted in a reduction in pelvic vascularity and inflammation, theoretically reducing the risk of postoperative adhesions. The preoperative use of danazol also makes laparoscopic surgery possible for more patients.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Endometriosis Pregnadienes Premedication Premedication Combined Modality Therapy Combined Modality Therapy Danazol Danazol Endometriosis Endometriosis Female Female Humans Humans Peritoneal Diseases Peritoneal Diseases Peritoneal Diseases Postoperative Complications

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (6)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:12:41.142639+00:00
License: CC0 · commercial use OK